Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solvent Crystallization . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111518229B reveals a novel method for removing elemental impurities in Sugammadex Sodium. Achieve ICH compliance and reduced manufacturing costs with scalable purification.
Advanced recrystallization patent for Hepatitis C drug intermediates. Delivers high-purity crystals, solvent recovery, and scalable manufacturing for global supply chains.
Patent CN104610385B details advanced purification for glucosamine HCl. Enhances yield and supply chain reliability for pharmaceutical and food additive manufacturers.
Advanced purification technology for dehydroabietic acid ensures high purity and supply chain stability for fine chemical intermediates manufacturing globally.
Patent CN103764664B reveals an acetone-based purification method for Erythromycin Thiocyanate, offering superior purity and cost reduction in API manufacturing.
Patent CN104974036A details a DMF-based purification method for Trimesic Acid, offering lower energy consumption and enhanced supply chain reliability for global manufacturers.
Patent CN102329328B reveals a novel purification method for Ceftizoxime Sodium, significantly enhancing purity and reducing toxic impurities for reliable pharmaceutical supply chains.
Patent CN107400156B details a solvent-based resolution of Antcin K epimers, offering high purity and cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN110627925A details a novel refining method for Sugammadex Sodium, ensuring superior purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN110857279B reveals a low-energy purification method for AMPS, ensuring high purity and yield for cost reduction in water treatment agent manufacturing.
Patent CN1313471C reveals mixed solvent crystallization for Mezlocillin Sodium. Enhances purity, yield, and supply chain stability for pharmaceutical manufacturing partners globally.
Advanced refining process for medicinal o-benzoyl sulfonyl imide salt achieving over 99.9 percent purity. Cost-effective purification removing stubborn impurities for pharmaceutical applications.
Patent CN107118248A reveals advanced purification for Deslanoside. Achieve superior purity and yield for reliable pharmaceutical intermediates supply chain optimization.
Analysis of patent CN103772401A reveals a novel ethyl acetate refining method for Asenapine intermediates, boosting yield to 98% and ensuring high purity for pharmaceutical manufacturing.
Patent CN115960011B details a novel purification method reducing free amine content significantly. This breakthrough ensures high-purity curing agents for scalable polymer additive manufacturing.
Novel solvent crystallization method removes dimer impurities, ensuring >99.5% purity for schizophrenia treatment APIs.
Patent CN115806481B reveals a novel solvent crystallization-weak base method for L-menthyl formic acid, ensuring high purity and scalable production for global supply chains.
Patent CN103102357A details a novel ethanol-water crystallization method for Cefuroxime sodium, offering safer production, superior purity, and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN105348167A details a novel methanol-based purification method achieving 99.9% purity. This ensures supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel solvent crystallization technology ensures 98% purity. Reduces steps for furandicarboxylic acid manufacturing. Reliable supply chain partner.